You are here: Industry Insights > T cells

News List

Persistent T cell response to omicron after infection and vaccination FirstWordPharma
January 20, 2022
The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognise omicron...
New target for COVID-19 vaccines identified WorldPharmaNews
November 11, 2021
Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, concludes new research carried out by UCL scientists.
Researchers find potential path to a broadly protective COVID-19 vaccine using T cells firstwordpharma
July 06, 2021
Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.
Common Immune Drug Methotrexate May Hamper Response to COVID-19 Vaccine drugs
May 27, 2021
A widely used medicine for autoimmune diseases may lower people's immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests.
Early functional SARS-COV-2 specific T cell response may prevent severe infection worldpharmanews
February 02, 2021
Humoral and cellular adaptive immunity are two immune mechanisms that act against pathogens. Humoral immunity is mediated by antibodies, while cellular immunity does not involve antibodies and is, instead, facilitated by T cells.
Vaccine delivered via skin scarification could help fight respiratory diseases europeanpharmaceuticalreview
January 29, 2021
According to a new study, vaccines delivered via skin scarification were better at inducing T cell activity in pre-clinical animal models.
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity worldpharmanews
September 18, 2020
Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more harm than good during the acute phase of COVID-19.
Scientists uncover SARS-CoV-2-specific T cell immunity in recovered COVID-19 and SARS patients worldpharmanews
July 17, 2020
The study by scientists from Duke-NUS Medical School, in close collaboration with the National University of Singapore (NUS) Yong Loo Lin School of Medicine, Singapore General Hospital (SGH) and National Centre for Infectious Diseases (NCID) was ...
Scientists focus on how immune system T cells fight coronavirus in absence of antibodies expresspharma
July 13, 2020
Recent studies show that some recovered patients who tested negative for coronavirus antibodies did develop T cells in response to their COVID-19 infection.
Scottish firm to trial T cells as possible COVID-19 treatment expresspharma
July 01, 2020
TC BioPharm (TCB) said it would conduct the trial at the Edinburgh Royal Infirmary, using gamma-delta T cells in a technique it has previously used on cancer patients.

Previous page 1 2 Next page